6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
Clinical trial NCT00352144 · COMPLETED
Trial details
- NCT number
- NCT00352144
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-10-01
- Enrollment
- 830
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.